Oklo’s Stock Jumps 265% Y/Y as It Secures 1.2 GW Meta Power Deal
Oklo stock has surged 265% year over year and 30% year to date, pushing its market cap to $15 billion with no current revenue. It signed a 1.2 GW power campus deal with Meta Platforms, advancing its small modular reactor tech and boosting long-term PPA prospects.
1. Stellar Stock Performance in 2025
Oklo’s shares have captured investor enthusiasm throughout 2025, delivering a roughly 265% gain over the past 12 months and adding nearly 30% in the first week of January. Trading volumes have surged to an average of 34 million shares daily, more than double its long-term average, as speculative and institutional buyers chase the small modular reactor pioneer. The company’s $16 billion market capitalization now positions it among the fastest-rising clean-energy names of the year.
2. Business Model and Growth Catalysts
Oklo is developing fast-spectrum microreactors that recycle their own fuel, planning to own and operate each installation. Under long-term power purchase agreements, the company aims to generate stable recurring revenues once its first Aurora demonstration plant is online. Parallel to power generation, Oklo is investing in radioisotope production through its Atomic Alchemy subsidiary and recently secured a Department of Energy agreement to build a pilot facility for medical and industrial isotopes, opening an adjacent revenue stream with potentially high margins.
3. Regulatory and Execution Risks
Despite rapid progress through the U.S. Nuclear Regulatory Commission pre-application stages, Oklo has yet to obtain a full design license or operate a commercial-scale power unit. Any delays or unexpected technical challenges during the remainder of the multi-year approval process could postpone revenue generation and strain cash reserves. The start-up has no operating reactors today and remains unprofitable, making timely regulatory clearance critical to justify its current valuation.
4. Long-Term Upside and Investor Considerations
While near-term upside may be limited by unproven technology and a lack of current revenues, Oklo’s long-range potential remains significant if it secures licensing and proves its reactor designs at scale. Investors with multi-year horizons may find value in a company strategically positioned at the forefront of next-generation nuclear energy and radioisotope supply. For those seeking lower risk exposure, nuclear energy exchange-traded funds could provide diversified participation in the sector’s anticipated growth.